Fidelity Investments’s BeOne Medicines Ltd ONC Stock Holding History

Fidelity Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1B	Sell	3,693,610 -299,017	-7%	-$96.8M	0.06%	272
2025 Q4	$1.21B	Buy	3,992,627 +207,692	+5%	+$68M	0.06%	244
2025 Q3	$1.29B	Buy	3,784,935 +335,142	+10%	+$102M	0.07%	233
2025 Q2	$835M	Sell	3,449,793 -3,783	-0.1%	-$928K	0.05%	325
2025 Q1	$940M	Buy	3,453,576 +1,605,513	+87%	+$375M	0.06%	268
2024 Q4	$341M	Buy	1,848,063 +188,052	+11%	+$38.4M	0.02%	606
2024 Q3	$373M	Buy	1,660,011 +12,855	+0.8%	+$2.31M	0.02%	581
2024 Q2	$235M	Sell	1,647,156 -33,307	-2%	-$5.13M	0.02%	727
2024 Q1	$263M	Sell	1,680,463 -40,840	-2%	-$6.58M	0.02%	677
2023 Q4	$310M	Sell	1,721,303 -631,427	-27%	-$114M	0.02%	579
2023 Q3	$423M	Buy	2,352,730 +69,297	+3%	+$13.7M	0.04%	441
2023 Q2	$407M	Sell	2,283,433 -216,923	-9%	-$50M	0.03%	480
2023 Q1	$539M	Sell	2,500,356 -163,369	-6%	-$39.2M	0.05%	381
2022 Q4	$586M	Buy	2,663,725 +57,335	+2%	+$10.5M	0.06%	335
2022 Q3	$351M	Sell	2,606,390 -286,373	-10%	-$49.2M	0.04%	464
2022 Q2	$468M	Sell	2,892,763 -520,874	-15%	-$81.4M	0.05%	393
2022 Q1	$644M	Sell	3,413,637 -211,696	-6%	-$45M	0.05%	360
2021 Q4	$982M	Sell	3,625,333 -186,667	-5%	-$63M	0.07%	251
2021 Q3	$1.38B	Sell	3,812,000 -478,468	-11%	-$156M	0.11%	153
2021 Q2	$1.47B	Sell	4,290,468 -126,027	-3%	-$41.7M	0.12%	147
2021 Q1	$1.54B	Sell	4,416,495 -286,012	-6%	-$94.7M	0.13%	140
2020 Q4	$1.22B	Sell	4,702,507 -377,360	-7%	-$104M	0.11%	172
2020 Q3	$1.46B	Sell	5,079,867 -365,394	-7%	-$85.9M	0.15%	115
2020 Q2	$1.03B	Sell	5,445,261 -272,659	-5%	-$44.4M	0.11%	163
2020 Q1	$704M	Buy	5,717,920 +313,592	+6%	+$49M	0.1%	191
2019 Q4	$896M	Sell	5,404,328 -257,807	-5%	-$42.8M	0.1%	193
2019 Q3	$693M	Buy	5,662,135 +38,107	+0.7%	+$5.06M	0.08%	237
2019 Q2	$697M	Buy	5,624,028 +17,090	+0.3%	+$2.17M	0.08%	236
2019 Q1	$740M	Buy	5,606,938 +12,765	+0.2%	+$1.72M	0.09%	222
2018 Q4	$785M	Buy	5,594,173 +128,072	+2%	+$17M	0.11%	168
2018 Q3	$941M	Buy	5,466,101 +90,072	+2%	+$15.1M	0.11%	175
2018 Q2	$826M	Buy	5,376,029 +19,547	+0.4%	+$3.49M	0.1%	198
2018 Q1	$900M	Buy	5,356,482 +847,894	+19%	+$115M	0.11%	187
2017 Q4	$441M	Buy	4,508,588 +18,640	+0.4%	+$1.71M	0.05%	389
2017 Q3	$465M	Buy	4,489,948 +499,892	+13%	+$37.3M	0.06%	352
2017 Q2	$180M	Buy	3,990,056 +2,308	+0.1%	+$91K	0.02%	716
2017 Q1	$146M	Buy	3,987,748 +107,323	+3%	+$3.91M	0.02%	829
2016 Q4	$118M	Buy	3,880,425 +593,896	+18%	+$18.7M	0.02%	902
2016 Q3	$101M	Buy	3,286,529 +986,192	+43%	+$28.6M	0.01%	967
2016 Q2	$68.5M	Buy	2,300,337 +583,277	+34%	+$17.1M	0.01%	1141
2016 Q1	$50.3M	Buy	+1,717,060	New	+$48.6M	0.01%	1242